In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
Active Ingredient Prescribing on computer-generated prescriptions became mandatory for prescribers from 1 February 2021. Most prescribing software has been updated to reflect the new requirement. There is also information and resources for prescribers available from the Safety Commission, including medicines that are excluded from the requirements and medicines for which prescribers are recommended to consider including a brand.
Since its national roll-out, the Pharmacy Guild of Australia has been receiving reports from pharmacists about prescriptions for which there are significant safety concerns. Some of the problems relate to specific software and it is important that prescribers report any identified problems to their software provider.
Some prescriptions are confusing or unclear (e.g. omission of strength) and require clarification from the prescriber before they can be dispensed. Other examples include prescriptions in which the medicine is incomplete (e.g. ‘Insulin 100iu/ml vial’ without specifying the type of insulin). In such cases, delays in the pharmacist clarifying the prescription with the prescriber may have significant consequences for patients.
Pharmacists are reporting prescriptions for multiple ingredients in which the strengths do not correlate with the ingredient. For example, Targin 5/2.5mg appears as naloxone/oxycodone 5/2.5mg rather than oxycodone/naloxone 5/2.5mg.
There are also examples of prescriptions being generated that are not consistent with the recommendations from the Safety Commission. As an example, a prescription for four or more active ingredients (e.g. Bexsero) should be prescribed by brand. Likewise, the Safety Commission recommends for high-risk medicines such as insulin or warfarin that prescribers include a brand on the prescription.
Pharmacists are also reporting that some patients are upset and confused and worried that they have the wrong prescriptions. Prescribers can help allay any concerns when writing the prescription and this can be reinforced when the patient presents to the pharmacy.
If you are issuing an electronic token prescription, information which is entered into the ‘notes section’ when prescribing (eg clarification of brand intention for a combined oral contraceptive or clarification of strength of drug if it is not clear from software) is considered part of the legal prescription and can be used by pharmacists. However, if issuing a paper prescription (even if it is sent via a prescription delivery service) the legislation states that all pertinent information including strength of drug must be printed on the prescription, and as such electronic notes associated are NOT sufficient for the pharmacist to legally dispense the prescription.
The Pharmacy Guild of Australia and the Primary Health Network are encouraging all prescribers and pharmacists to be extra vigilant in checking computer generated prescriptions and communicating with each other and their patients to avoid prescription-related errors and allaying any patient concerns.
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
COVID-19 weekly update – 02 JANUARY 2023 COVID-19 cases in the region Please note: From next week the latest COVID-19 information will be included in the Sydney Health Weekly newsletter, rather than separated at the top. We will still provide COVID-19 related information as well as the dedicated COVID-19 latest…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. Randwick scientist and grandmother Hilda Stender shared this: What exercise did you do yesterday? I’ve had two knee replacements – one four years ago and the other six months ago. As a result,…
Immunisation weekly update – 1 February 2023 Childhood immunisation overdue reports CESPHN is inviting general practices to sign up to receive a regular report extracted on your behalf from the Australian Immunisation Register (AIR) which is specific to your practice. This report contains all children aged 0-5 living in the CESPHN region…
Australian Digital Health Agency (ADHA) digital health webinars Implementing MyHealth Record Policies in your organisation Thu 9 Feb 23, 12.30-1.00 pm – learn how to implement and maintain a My Health Record Security and Access policy in your organisation. Understand the importance of the Responsible Officer (RO) and Organisational Maintenance…
UNSW research – Palliative care and intellectual disability A research team led by Professor Julian Trollor at the Department of Developmental Disability Neuropsychiatry, UNSW Sydney, aims to design, implement, and evaluate a new palliative care service for people with intellectual disability. This is important because people with intellectual disability often…
GP support needed: Shared e-Care plan study for follow-up of colorectal and breast cancers This research evaluates shared care using a new interactive e-care plan being implemented through cancer services in Prince of Wales and St George public and private hospitals. Through the e-care plan GPs, cancer specialists and patients…